Evolution of neoplastic cell lineages in Barrett oesophagus

Nature Genetics

Volumn 22, Issue 1, 1999, Pages 106-109

  Barrett, Michael T ^a   Sanchez, Carissa A ^a   Prevo, Laura J ^a   Wong, David J ^a,b   Galipeau, Patricia C ^a   Paulson, Thomas G ^a,c   Rabinovitch, Peter S ^a,c   Reid, Brian J ^a,c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ANEUPLOIDY; ARTICLE; BARRETT ESOPHAGUS; CANCER GENETICS; CELL LINEAGE; DNA METHYLATION; ESOPHAGUS CARCINOMA; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; PRECANCER; PRIORITY JOURNAL;

ADENOCARCINOMA; ANEUPLOIDY; BARRETT ESOPHAGUS; CELL DIFFERENTIATION; CELL LINEAGE; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 18; CHROMOSOMES, HUMAN, PAIR 5; CHROMOSOMES, HUMAN, PAIR 9; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; HUMANS; LOSS OF HETEROZYGOSITY; MODELS, GENETIC; MUTATION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032953491     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/8816     Document Type: Article

References (30)

1. Nowell, P.C. The clonal evolution of tumor cell populations. Science 194, 23-28 (1976).
2. Fearon, E.R. & Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell 61, 759-767 (1990).
3. Boland, C.R., Sato, J., Appelman, H.D., Besalier, R.S. & Feinberg, A.P. Microallelotyping defines the sequence and tempo of allelic losses at tumor suppressor gene loci during colorectal cancer progression. Nature Med. 1, 902-909 (1995).
4. Spechler, S.J. Endoscopic surveillance for patients with Barrett esophagus: does the cancer risk justify the practice? Ann. Intern. Med. 106, 902-904 (1987).
5. Levine, D.S. et al. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastroenterology 105, 40-50 (1993).
6. Rabinovitch, P.S. Reid, B.J., Haggitt, R.C., Norwood, T.H. & Rubin, C.E. Progression to cancer in Barrett's esophagus is associated with genomic instability. Lab. Invest. 60, 65-71 (1989).
7. Neshat, K. et al. p53 mutations in Barrett's adenocarcinoma and high-grade dysplasia. Gastroenterology 106, 1589-1595 (1994).
8. Barrett, M.T., Galipeau, P.C., Sanchez, C.A., Emond, M.J. & Reid, B.J. Determination of the frequency of loss of heterozygosity in esophageal adenocarcinoma by cell sorting, whole genome amplification and microsatellite polymorphisms. Oncogene 12, 1873-1878 (1996).
9. Wong, D.J., Barrett, M.T., Stoger, R., Emond, M.J. & Reid, B.J. p16INK4a promoter is hypermethylated at a high frequency in esophageal adenocarcinomas. Cancer Res. 57, 2619-2622 (1997).
10. Galipeau, P.C. et al. 17p (p53) allelic losses, 4N (G2/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus. Proc. Natl Acad. Sci. USA 93, 7081-7084 (1996).
11. Barrett, M.T. et al. Allelic loss of 9p21 and mutation of the CDKN2/p16 gene develop as early lesions during neoplastic progression in Barrett's esophagus. Oncogene 13, 1867-1873 (1996).
12. Reid, B.J., Haggitt, R.C., Rubin, C.E. & Rabinovitch, P.S. Barrett's esophagus. Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma. Gastroenterology 93, 1-11 (1987).
13. Reid, B.J. et al. Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort. Gastroenterology 102, 1212-1219 (1992).
14. Blount, P.L. et al. Clonal ordering of 17p and Sq allelic losses in Barrett dysplasia and adenocarcinoma. Proc. Natl Acad. Sci. USA 90, 3221-3225 (1993).
15. Blount, P.L. et al. 17p allelic losses in diploid cells of patients with Barrett's esophagus who develop aneuploidy Cancer Res. 54, 2292-2295 (1994).
16. Mao, L. et al. Clonal genetic alterations in the lungs of current and former smokers. J. Natl Cancer Inst. 89, 857-862 (1997).
17. Bedi, G.C., Westra, W.H., Gabrielson, E., Koch, W. & Sidransky, D. Multiple head and neck tumors: evidence for a common clonal origin. Cancer Res. 56, 2484-2487 (1996).
18. Califano, J. et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res. 56, 2488-2492 (1996).
19. Sidransky, D. et al. Clonal expansion of p53 mutant cells is associated with brain tumour progression Nature 355, 846-847 (1992).
20. Gazdar, A.F. et al. Molecular genetic changes found in human lung cancer and its precursor lesions. Cold Spring Harb. Symp. Quant. Biol. 59, 565-572 (1994).
21. Kuukasjarvi, T. et al. Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer. Cancer Res. 57, 1597-1604 (1997).
22. Wu, T. et al. Genetic alterations in Barrett esophagus and adenocarcinomas of the esophagus and esophagogastric junction region. Am. J. Pathol. 153, 287-294 (1998).
23. van der Burgh, A., Dees, J., Hop, W.C.J. & van Blankenstein, M. Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus. Gut 39, 5-8 (1996).
24. Mao, L. et al. Clonal genetic alterations in the lungs of current and former smokers. J. Natl Cancer Inst. 89, 857-862 (1997).
25. Correa, P. et al. Gastric precancerous process in a high risk population: cohort follow-up. Cancer Res. 50, 4737-4740 (1990).
26. Rozen, P., Baratz, M., Fefer, F. & Gilat, T. Low incidence of significant dysplasia in a successful endoscopic surveillance program of patients with ulcerative colitis. Gastroenterology 108, 1361-1370 (1995).
27. Eide, T.J. Risk of colorectal cancer in adenoma-bearing individuals within a defined population. Int. J. Cancer 38, 173-176 (1985).
28. Petersen, S.E., Lorentzen, M. & Bichel, P. A mosaic subpopulation structure of human colorectal carcinomas demonstrated by flow cytometry. Flow Cytometry IV, 412-416 (1980).
29. Barrett, M.T., Schutte, M., Kern, S.E. & Reid, B.J. Allelic loss and mutational analysis of the DPC4 gene in esophageal adenocarcinoma. Cancer Res. 56, 4351-4353 (1996).
30. Levine, D.S. et al. Distribution of aneuploid cell populations in ulcerative colitis with dysplasia or cancer. Gastroenterology 101, 1198-1210 (1991).